Press Release: RXO Reports Third-Quarter Results with Coyote Integration Ahead of Schedule and Complementary Services Momentum

Dow Jones
2024-11-07
        Total equity                            1,652             594 
                                           ----------       --------- 
            Total liabilities and 
             equity                     $       3,392    $      1,825 
                                           ==========       ========= 
 
 
                                RXO, Inc. 
             Condensed Consolidated Statements of Cash Flows 
                                (Unaudited) 
 
                                      Nine Months Ended September 30, 
                                 ----------------------------------------- 
(In millions)                              2024                 2023 
------------------------------   ------------------------  --------------- 
Operating activities 
    Net income (loss)              $             (265)      $        2 
Adjustments to reconcile net 
income (loss) to net cash from 
operating activities 
    Depreciation and 
     amortization expense                          54               52 
    Stock compensation expense                     17               16 
    Deferred tax benefit                          (12)              (1) 
    Deemed non-pro rata 
    distribution                                  216               -- 
    Other                                           3                4 
Changes in assets and 
liabilities 
    Accounts receivable                            (8)             114 
    Other assets                                   22              (13) 
    Accounts payable                              (47)             (56) 
    Accrued expenses and other 
     liabilities                                   15              (48) 
                                 ---  ---------------          ------- 
Net cash provided by (used in) 
 operating activities                              (5)              70 
                                 ---  ---------------          ------- 
Investing activities 
    Payment for purchases of 
     property and equipment                       (33)             (46) 
    Business acquisition, net 
     of cash acquired                          (1,019)              -- 
    Other                                          --               (1) 
                                 ---  ---------------          ------- 
Net cash used in investing 
 activities                                    (1,052)             (47) 
                                 ---  ---------------          ------- 
Financing activities 
    Proceeds from borrowings 
    on revolving credit 
    facilities                                    203               -- 
    Repayment of borrowings on 
     revolving credit 
     facilities                                  (193)              -- 
    Proceeds from issuance of 
    common stock and 
    pre-funded warrants                         1,125               -- 
    Payment for equity issuance 
     costs                                        (30)              -- 
    Payment for tax 
     withholdings related to 
     vesting of stock 
     compensation awards                           (4)             (12) 
    Repurchase of common stock                     --               (2) 
    Repayment of debt and 
     finance leases                                (3)              (3) 
    Other                                           9               -- 
                                 ---  ---------------          ------- 
Net cash provided by (used in) 
 financing activities                           1,107              (17) 
                                 ---  ---------------          ------- 
    Effect of exchange rates 
    on cash, cash equivalents 
    and restricted cash                            --               -- 
Net increase in cash, cash 
 equivalents and restricted 
 cash                                              50                6 
Cash, cash equivalents, and 
 restricted cash, beginning of 
 period                                             5               98 
                                 ---  ---------------          ------- 
Cash, cash equivalents, and 
 restricted cash, end of 
 period                            $               55       $      104 
                                 ===  ===============          ======= 
Supplemental disclosure of 
cash flow information: 
    Leased assets obtained in 
     exchange for new operating 
     lease liabilities             $               97       $       60 
    Leased assets obtained in 
     exchange for new finance 
     lease liabilities                             --                1 
    Cash paid for income taxes, 
     net                                            3               25 
    Cash paid for interest, net                    13               18 
 
 
                          RXO, Inc. 
          Revenue Disaggregated by Service Offering 
                         (Unaudited) 
 
                      Three Months Ended   Nine Months Ended 
                        September 30,        September 30, 
                      ------------------  ------------------- 
(In millions)          2024     2023       2024     2023 
-------------------    -----    ----       -----    ----- 
Revenue 
    Truck brokerage   $  655   $ 591      $1,762   $1,748 
    Last mile            268     256         765      757 
    Managed 
     transportation      151     163         459      536 
    Eliminations         (34)    (34)       (103)     (92) 
                       -----    ----       -----    ----- 
Total                 $1,040   $ 976      $2,883   $2,949 
                       =====    ====       =====    ===== 
 
 
                                             RXO, Inc. 
         Reconciliation of Net Income (Loss) to Adjusted EBITDA and Adjusted EBITDA Margin 
                                            (Unaudited) 
 
                                                                       Twelve Months 
                                                                           Ended 
                       Three Months Ended        Nine Months Ended       September     Year Ended 
                          September 30,            September 30,            30,       December 31, 
                     -----------------------  -----------------------  -------------  ------------- 
                                                                           2024 
(In millions)         2024        2023         2024        2023             (4)        2023 
------------------    -----       ----  ----   -----       -----  ---      -----       -----  ----- 
Reconciliation of 
Net Income (Loss) 
to Adjusted 
EBITDA 
    Net income 
     (loss)          $ (243)     $  (1)       $ (265)     $    2        $   (263)     $    4 
    Interest 
     expense, net         6          8            22          24              30          32 
    Income tax 
     provision 
     (benefit)            1         (2)           (6)         (2)             (4)         -- 
    Depreciation 
     and 
     amortization 
     expense             21         16            54          52              69          67 
    Transaction and 
     integration 
     costs               30          2            38          12              38          12 
    Restructuring 
     and other 
     costs (3)          218          3           233          13             237          17 
                      -----       ----  ----   -----       -----  ---      -----       -----  ----- 
Adjusted EBITDA (1)  $   33      $  26        $   76      $  101        $    107      $  132 
                      =====       ====  ====   =====       =====  ===      =====       =====  ===== 
 
Revenue              $1,040      $ 976        $2,883      $2,949        $  3,861      $3,927 
Adjusted EBITDA 
 margin (1) (2)         3.2%       2.7%          2.6%        3.4%            2.8%        3.4% 
 
 
(1)    See the "Non-GAAP Financial Measures" section of the press release. 
(2)    Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by 
       Revenue. 
(3)    Other for the three, nine and trailing twelve months ended September 
       30, 2024 reflects a one-time charge of $216 million representing a 
       deemed non-pro rata distribution in connection with the private 
       placement common stock issuance completed in August 2024. 
(4)    Trailing twelve months ended September 30, 2024 is calculated as the 
       nine months ended September 30, 2024 plus the twelve months ended 
       December 31, 2023 less the nine months ended September 30, 2023. 
 
 
RXO, Inc. Reconciliation of Net Income (Loss) to Adjusted Net Income 
         and Adjusted Diluted Earnings Per Share (Unaudited) 
 
                          Three Months Ended     Nine Months Ended 
                            September 30,          September 30, 
                         --------------------  ---------------------- 
(Dollars in millions, 
shares in thousands, 
except per share 
amounts)                   2024       2023       2024       2023 
----------------------    -------    -------    -------    ------- 
Reconciliation of Net 
Income (Loss) to 
Adjusted Net Income 
and Adjusted Diluted 
Earnings Per Share 
    Net income (loss)    $   (243)  $     (1)  $   (265)  $      2 
    Amortization of 
     intangible assets          5          4         11         10 
    Transaction and 
     integration costs         30          2         38         12 
    Restructuring and 
     other costs (3)          218          3        233         13 
    Income tax 
     associated with 
     adjustments above 
     (1)                       (3)        (2)       (10)        (8) 
                          -------    -------    -------    ------- 
Adjusted net income (2)  $      7   $      6   $      7   $     29 
                          =======    =======    =======    ======= 
 
Adjusted diluted 
 earnings per share 
 (2)                     $   0.05   $   0.05   $   0.06   $   0.24 
 
Weighted-average 
shares outstanding 
    Diluted               136,968    119,416    125,536    119,415 
 
 

(MORE TO FOLLOW) Dow Jones Newswires

November 07, 2024 06:00 ET (11:00 GMT)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10